## IBM: International Business Machines Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -1.8% below STRENGTH zone (3.0-6.0%); PEG 2.03 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($282.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. IBM Stock Is an ‘Acceleration Story,’ Say Analysts. Why Adobe Doesn’t Get the Same Vote of Confidence.**
- Source: Barron's | 20260105T123900 | Bullish | Relevance: 100%
- Jefferies analysts upgraded IBM stock to Buy from Hold and raised its price target to $360 from $300, citing anticipated growth in software in 2026. Conversely, the analysts did not extend the same confidence to Adobe, effectively moving to the sidelines on the design-software maker. They characterized IBM as an "acceleration story" due to its expected growth.

**2. IBM (IBM) Valuation Check After Recent Pullback and Strong 1-Year Run**
- Source: Simply Wall Street | 20260105T012327 | Neutral | Relevance: 100%
- IBM (IBM) has experienced a recent pullback, dropping 5% over the past month, but still boasts a strong 34.31% return over the past year. Analysts generally see a slim upside from its current price of $291.5, with a consensus target of $281.316, although some bullish forecasts reach $350. The article questions whether IBM's future growth from hybrid cloud and AI is already factored into its current valuation, noting its P/E ratio is higher than peers, yet Simply Wall St's fair ratio suggests potential for the market to edge higher.

**3. IBM stock slips below $300 as Wall Street braces for jobs data and Big Blue earnings**
- Source: ts2.tech | 20260105T004157 | Somewhat-Bearish | Relevance: 100%
- IBM shares closed down 1.6% at $291.50 on Friday, slipping under the $300 mark, as Wall Street anticipates key U.S. jobs and inflation data, which could influence interest-rate expectations. Investors are also looking ahead to IBM’s fourth-quarter earnings announcement set for January 28, where focus will be on software growth, consulting demand, and free cash flow. The stock's performance is further impacted by broader market trends and the company's strategic moves into hybrid-cloud and AI, tempered by execution risks and competitive pressures.

**4. Fulton Bank N.A. Sells 4,810 Shares of International Business Machines Corporation $IBM**
- Source: MarketBeat | 20260103T142956 | Somewhat-Bullish | Relevance: 100%
- Fulton Bank N.A. has reduced its stake in International Business Machines Corporation (IBM) by 17.7%, selling 4,810 shares and retaining 22,411 shares valued at $6.323 million. This comes as IBM exceeded Q3 earnings expectations, reporting $2.65 EPS against a $2.45 estimate, and revenue of $16.33 billion. The company maintains a "Moderate Buy" analyst rating with a target price of $293.38 and pays a quarterly dividend of $1.68.

**5. IBM stock today: Shares slip to $291.50 as 2026 begins — what investors watch next**
- Source: ts2.tech | 20260103T135300 | Neutral | Relevance: 100%
- IBM shares closed down about 1.7% at $291.50 on Friday, with investors focusing on upcoming U.S. jobs and inflation reports, and IBM's Jan. 28 earnings announcement. The stock has fallen for three consecutive sessions but significantly outperformed over the past 12 months, driven by demand for hybrid cloud and AI offerings. A recent regulatory filing revealed a director deferred board fees into "Promised Fee Shares" tied to IBM common stock.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | RBC Capital | $350 | $300 | +17% |
| 2026-01-05 | Jefferies | $360 | $300 | +20% |
| 2025-12-09 | Stifel | $325 | $295 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | RBC Capital | main | Outperform |
| 2026-01-05 | Jefferies | up | Buy |
| 2025-12-09 | Stifel | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($1.06M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (+0.8%)
- Blackrock Inc.: 8.2% (-1.1%)
- State Street Corpora: 5.8% (-0.1%)
- JPMORGAN CHASE & CO: 3.6% (+49.8%)
- Geode Capital Manage: 2.4% (+1.5%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.6% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +16%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.03 elevated, pricing in significant growth expectations. Forward P/E 24.1x stretched relative to 7% growth. Quality metrics strong (ROE 30%). Balance sheet: $2.5B free cash flow. Analyst sentiment positive (3 raises, avg +16%, $349 target (+18%)). Insider buying signal ($1.1M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $275.7B |
| Beta | 0.70 |
| 52W Range | $214.50 - $324.90 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.03 |
| Forward P/E | 24.1 |
| Current P/E | 25.9 |
| YoY Growth | 7.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.2% to -1.8% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram bearish (-1.57), momentum weakening. RSI neutral at 40. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.77% (CS: 17) | Neutral |
| RSI_14 | 40.3 | Neutral |
| MACD Histogram | -1.57 | Bearish |
| vs SMA20 | 0.970x | Below |
| vs SMA50 | 0.970x | Below |
| vs SMA200 | 1.084x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $295.04
- **Stop Loss:** $282.18 (4.4% risk)
- **Target:** $307.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 89
- **Position Value:** $26,258.56
- **Portfolio %:** 26.26%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-28 (Est: $4.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.45 | $2.65 | +8.3% |
| 2025Q2 | $2.65 | $2.80 | +5.5% |
| 2025Q1 | $1.43 | $1.60 | +12.1% |
| 2024Q4 | $3.78 | $3.92 | +3.8% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*